Complete vaccination with the four-component, protein-based meningococcal serogroup B vaccine (4CMenB; Bexsero) was found to be effective in the prevention of invasive serogroup B and non-serogroup B ...

PARIS — All the way back in 1907, The Lancet published an article on a gonorrhea vaccine trial. Today, after continuous research throughout the intervening 110-plus years, scientists may finally have ...

Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhea, according to the results of the world's largest ...

Newswise — The meningococcal B (MenB) vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhoea in the Northern ...

The meningococcal B vaccine is ineffective in gonorrhea prevention among men who have sex with men (MSM) at high risk of infection, according to findings from the world's largest randomized controlled ...

PORTLAND, Ore. (KTVZ) — A vaccine that prevents meningococcal B infection may also be protective against the sexually transmitted disease gonorrhea, according to an Oregon Health Authority study ...

Meningococcal disease can affect any one, at any age. 4 The reported incidence of Invasive Meningococcal Disease varies by region, ranging from less than 0.5 cases per 100,000 in North America and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhea, according to the results of the world's largest ...

Pfizer, Inc. PFE announced positive top-line data from a pivotal phase III study. The study evaluated the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal ...